4.7 Review

Intraocular Biopsy and ImmunoMolecular Pathology for Unmasking Intraocular Inflammatory Diseases

Journal

JOURNAL OF CLINICAL MEDICINE
Volume 8, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/jcm8101733

Keywords

intraocular inflammation; intraocular biopsy; masquerade syndrome; intraocular lymphoma; endophthalmitis; molecular pathology; immunohistochemistry; laser capture microdissection; qPCR

Ask authors/readers for more resources

Intraocular inflammation can hide a variety of eye pathologies. In 33% of cases, to obtain a correct diagnosis, investigation of the intraocular sample is necessary. The combined analyses of the intraocular biopsy, using immuno-pathology and molecular biology, point to resolve the diagnostic dilemmas in those cases where history, clinical tests, and ophthalmic and systemic examinations are inconclusive. In such situations, the teamwork between the ophthalmologist and the molecular pathologist is critically important to discriminate between autoimmune diseases, infections, and intraocular tumors, including lymphoma and metastases, especially in those clinical settings known as masquerade syndromes. This comprehensive review focuses on the diagnostic use of intraocular biopsy and highlights its potential to enhance research in the field. It describes the different surgical techniques of obtaining the biopsy, risks, and complication rates. The review is organized according to the anatomical site of the sample: I. anterior chamber containing aqueous humor, II. iris and ciliary body, III. vitreous, and IV. choroid and retina. We have excluded the literature concerning biopsy for choroidal melanoma and retinoblastoma, as this is a specialized area more relevant to ocular oncology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

SOX2 boosts major tumor progression genes in prostate cancer and is a functional biomarker of lymph node metastasis

Marco Vincenzo Russo, Silvia Esposito, Maria Grazia Tupone, Lamberto Manzoli, Irma Airoldi, Paolo Pompa, Luca Cindolo, Luigi Schips, Carlo Sorrentino, Emma Di Carlo

ONCOTARGET (2016)

Article Oncology

Interleukin-30 Promotes Breast Cancer Growth and Progression

Irma Airoldi, Claudia Cocco, Carlo Sorrentino, Domenico Angelucci, Serena Di Meo, Lamberto Manzoli, Silvia Esposito, Domenico Ribatti, Maria Bertolotto, Laura Iezzi, Clara Natoli, Emma Di Carlo

CANCER RESEARCH (2016)

Article Oncology

Interleukin-30/IL27p28 Shapes Prostate Cancer Stem-like Cell Behavior and Is Critical for Tumor Onset and Metastasization

Carlo Sorrentino, Stefania L. Ciummo, Giuseppe Cipollone, Sara Caputo, Matteo Bellone, Emma Di Carlo

CANCER RESEARCH (2018)

Article Oncology

Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival

Carlo Sorrentino, Zhinan Yin, Stefania Ciummo, Paola Lanuti, Li-Fan Lu, Marco Marchisio, Matted Bellone, Emma Di Carlo

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)

Letter Biophysics

NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models

Stefano Baldoni, Loredana Ruggeri, Beatrice Del Papa, Daniele Sorcini, Francesco Guardalupi, Francesca Ulbar, Andrea Marra, Erica Dorillo, Arianna Stella, Raffaella Giancola, Bianca Fabi, Rosaria Sola, Sara Ciardelli, Filomena De Falco, Chiara Rompietti, Francesco Maria Adamo, Emanuela Rosati, Antonio Pierini, Carlo Sorrentino, Paolo Sportoletti, Mauro Di Ianni

BONE MARROW TRANSPLANTATION (2021)

Article Biochemistry & Molecular Biology

Oxidative Stress, Mutations and Chromosomal Aberrations Induced by In Vitro and In Vivo Exposure to Furan

Maria Teresa Russo, Gabriele De Luca, Nieves Palma, Paola Leopardi, Paolo Degan, Serena Cinelli, Gaetano Pepe, Pasquale Mosesso, Emma Di Carlo, Carlo Sorrentino, Piero Musiani, Riccardo Crebelli, Margherita Bignami, Eugenia Dogliotti

Summary: The study investigated the genotoxicity of furan and its reactive metabolite in mammalian cells and mouse models, revealing that both furan and BDA induce significant chromosomal damage but exhibit weak mutagenic activity. Inter-strand crosslinks (ICLs) are identified as key lesions for chromosomal damage, while oxidized base lesions are unlikely to play a critical role.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

NOTCH1 Activation Negatively Impacts on Chronic Lymphocytic Leukemia Outcome and Is Not Correlated to the NOTCH1 and IGHV Mutational Status

Stefano Baldoni, Beatrice Del Papa, Filomena De Falco, Erica Dorillo, Carlo Sorrentino, Chiara Rompietti, Francesco Maria Adamo, Manuel Nogarotto, Debora Cecchini, Elena Mondani, Estevao Carlos Silva Barcelos, Lorenzo Moretti, Maria Grazia Mameli, Bianca Fabi, Daniele Sorcini, Arianna Stella, Raffaella Giancola, Francesco Guardalupi, Francesca Ulbar, Sara Plebani, Valerio Guarente, Emanuela Rosati, Marta Di Nicola, Michele Marchioni, Mauro Di Ianni, Paolo Sportoletti

Summary: This study found that NOTCH1 activation is a negative prognostic factor in chronic lymphocytic leukemia (CLL) patients, significantly reducing Time To First Treatment (TTFT) regardless of NOTCH1 and IGHV mutation status. Activation of NOTCH2 and expression of JAGGED1 also influence clinical outcomes in this group, highlighting the need for further dedicated studies to refine CLL risk stratification using different components of the NOTCH network.

FRONTIERS IN ONCOLOGY (2021)

Article Cell Biology

The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs

Stefania Livia Ciummo, Luigi D'Antonio, Carlo Sorrentino, Cristiano Fieni, Paola Lanuti, Giorgio Stassi, Matilde Todaro, Emma Di Carlo

Summary: CXCL1 acts as an autocrine growth factor for BCSCs, promoting tumor progression and immune escape. Targeting the CXCL1/CXCR2 axis could restrain the BCSC compartment and improve the treatment of aggressive BC.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Immunology

Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival

Carlo Sorrentino, Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Emma Di Carlo

Summary: Colorectal cancer is a common cancer with a growing impact on public health. Immunotherapy shows promise in treatment, but resistance and limited patient eligibility are challenges. Understanding immune exhaustion in CRC is crucial for developing effective therapies.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome

Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, Cristiano Fieni, Paola Lanuti, Alice Turdo, Matilde Todaro, Emma Di Carlo

Summary: IL30 plays a crucial role in regulating the viability and growth of breast cancer stem cells (BCSC) through juxtacrine signals and mediators such as CXCL10 and IL23. Targeting IL30 could potentially restrain the BCSC compartment and counteract breast cancer progression by disrupting its autocrine loops and immune subversion pathways.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)

Article Oncology

CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality

Carlo Sorrentino, Luigi D'Antonio, Stefania Livia Ciummo, Cristiano Fieni, Lorena Landuzzi, Francesca Ruzzi, Simone Vespa, Paola Lanuti, Lavinia Vittoria Lotti, Pier Luigi Lollini, Emma Di Carlo

Summary: IL30 plays a crucial role in the development and progression of prostate cancer by regulating tumor driver genes and immunity-related genes. Targeting IL30 using CRISPR/Cas9-mediated therapy shows promise for clinical application.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Article Oncology

Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival

Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Simone Vespa, Lavinia Lotti, Carlo Sorrentino, Emma Di Carlo

Summary: IL-30 is involved in the proliferation and migration of colorectal cancer stem cells and CRC cells, and its inactivation inhibits tumorigenicity and metastatic ability.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Hematology

Comparison between peripheral blood progenitor cell collection on the 4th or 5th day of granulocyte colony-stimulating factor treatment in allogeneic stem cell donors: implications for hematopoietic progenitor cell apheresis guidelines

Cecilia Passeri, Ornella Iuliani, Mauro Di Ianni, Carlo Sorrentino, Raffaella Giancola, Luciano Abbruzzese, Franco M. Dallavalle, Salvatore Gattillo, Maria T. Mariano, Massimo Martino, Angelo Ostuni, Chiara Savignano, Luca Santoleri, Tiziana Tison, Michele Vacca, Patrizia Accorsi

BLOOD TRANSFUSION (2023)

Correction Oncology

Clinical impact of the lung tissue transcriptome in a teenager with multifocal invasive mucinous adenocarcinoma-a case report (vol 9, pg 793, 2020)

Emma Di Carlo, Giuseppe Cipollone, Felice Mucilli, Carlo Sorrentino

TRANSLATIONAL LUNG CANCER RESEARCH (2020)

No Data Available